Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2007
03/29/2007WO2007034508A1 An ultra-sensitive method for detection and quantification of substance
03/29/2007WO2007034507A2 Tetravalent dengue specific domain iii based chimeric recombinant protein
03/29/2007WO2007034284A1 Method to measure the total anti-oxidant capacity of a biological sample and kit thereof
03/29/2007WO2007034181A1 Association between the tdoa gene and osteoarthritis
03/29/2007WO2007034177A1 Reagents and methods for the detection of transmissible spongiform encephalopathy
03/29/2007WO2007034164A2 Diagnostic device
03/29/2007WO2007034160A2 Diagnostic methods based on polymorphisms of glucosyltransferase-like protein
03/29/2007WO2007034151A2 A method of screening mhc molecules
03/29/2007WO2007034132A1 Systems and methods for measuring multiphase flow in a hydrocarbon transporting pipeline
03/29/2007WO2007034131A1 Electro-chemical sensor
03/29/2007WO2007034021A1 Nanoparticle biosensor, method of preparing same and uses thereof
03/29/2007WO2007033514A1 Protein combination characterized in fluorescence resonance energy transfer, and the use thereof
03/29/2007WO2007033508A2 Organic compounds
03/29/2007WO2007033507A1 Blood sugar measurement device
03/29/2007WO2007033497A1 Library from toxin mutants, and methods of using same
03/29/2007WO2007033410A1 Method and apparatus for measuring properties of board products
03/29/2007WO2007016619A3 Screening method for the identification of compositions suitable for the treatment of oral cavity malodor associated with smoking a tobacco product
03/29/2007WO2007012849A3 MASS LABELS FOR BIOMOLECULES CONTAINING A 2,6-DIMETHYL-PIPERIDIN-l-YL METHYLENE OR A PYRIMIDIN-2-YL THIOMETHYLENE MASS MARKER MOIETY AND A SUCCINIMID-OXY-CARBONYL REACTIVE FUNCTIONAL GROUP
03/29/2007WO2007012614A3 Novel anti-igf-ir antibodies and uses thereof
03/29/2007WO2007011221A3 Anti fungal screening method
03/29/2007WO2007009816A3 Plexin d1 as a target for tumor diagnosis and therapy
03/29/2007WO2007006870A3 Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof
03/29/2007WO2007005881A3 Calibration system for use with lateral flow assay test strips
03/29/2007WO2007003860A3 Method for optical evaluation of a fluid
03/29/2007WO2007003859A3 Method for evaluating a mixture of oil products and biofuels
03/29/2007WO2007002088A3 Psat1s as modifiers of the pten/akt pathway and methods of use
03/29/2007WO2006137942A8 Methods for controlling the quality of metal nanocatalyst for growing high yield carbon nanotubes
03/29/2007WO2006136824A3 Ratiometric multicolour fluorescence correlation screening; agents for use therewith and methods of production thereof
03/29/2007WO2006134569A3 Rapid magnetic biosensor with integrated arrival time measurement
03/29/2007WO2006131677A3 Method for breast cancer diagnosis/prognosis
03/29/2007WO2006129054A3 Devices and methods for quantification of liquids in gas-condensate wells
03/29/2007WO2006128084A3 Trps1-mediated modulation of hair growth
03/29/2007WO2006127852A3 In situ heat induced antigen recovery and staining apparatus and method
03/29/2007WO2006127724A3 Spectroscopic analysis of a biological fluid reacted with an enzyme
03/29/2007WO2006126030A3 Malaria vaccines
03/29/2007WO2006126008A3 Improved immunoassay methods
03/29/2007WO2006122043A3 Diagnostic marker for diabetic vascular complications
03/29/2007WO2006116351A3 Method for the early detection of renal disease using proteomics
03/29/2007WO2006110881A3 Yersinia polypeptide vaccines, antibodies and immunomodulatory proteins
03/29/2007WO2006105111B1 Colloidal metal conjugates
03/29/2007WO2006094239A3 Fluorescence polarization assays for acetyltransferase/deacetylase activity
03/29/2007WO2006091962A3 Detection of compounds that affect therapeutic activity
03/29/2007WO2006089233A3 Methods and systems for diagnosis, prognosis and selection of treatment of leukemia
03/29/2007WO2006088823A3 Method for detecting misfolded proteins and prions
03/29/2007WO2006086454A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
03/29/2007WO2006066224A3 Virulence targeted antibiotics
03/29/2007WO2006053015A3 Composition and method for increasing apoptosis in cancer cells
03/29/2007WO2006043171A3 Methods of using alpha2delta-1 selective compounds
03/29/2007WO2006029209A3 Method for activating trpv4 channel receptors by agonists
03/29/2007WO2006013336A9 Hpv vaccine comprising peptides from host cell proteins
03/29/2007WO2005108977A3 Methods and systems for detection of macrolides
03/29/2007WO2005074524A3 Modified human interferon polypeptides and their uses
03/29/2007WO2005053505A8 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis
03/29/2007WO2003106655A3 Fibrous protein-immobilization systems
03/29/2007US20070074295 Schizophrenia related gene
03/29/2007US20070073189 Method and apparatus for penetrating tissue
03/29/2007US20070073188 Method and apparatus for penetrating tissue
03/29/2007US20070073047 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics
03/29/2007US20070072849 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
03/29/2007US20070072823 siRNA targeting survivin
03/29/2007US20070072807 Method of screening compounds
03/29/2007US20070072805 Fusion peptide-induced hemolysis effectively inhibited by peptides of the invention compared to virus-inhibitory peptide (VIRIP); peptide blocks cellular infection by HIV particles by interacting with the fusion peptide of HIV viral glycoprotein 41 (gp41) to prevent virus entry into thecell
03/29/2007US20070072794 Novel genes and proteins encoded thereby
03/29/2007US20070072309 Analytical compositions including nanometer-sized transducers, methods to make thereof, and devices therefrom
03/29/2007US20070072308 Methods of forming monolayers of phage-derived products and uses thereof
03/29/2007US20070072307 Methods of purifying Fc region containing proteins
03/29/2007US20070072304 System and method for identifying biological growth media
03/29/2007US20070072303 Method of chromatographic analysis of a protein solution
03/29/2007US20070072302 Method for quantitatively determining the LDL particle number in a distribution of LDL cholesterol subfractions
03/29/2007US20070072298 A conditioning buffer or osmolality adjuster, a lytic quaternary ammonium surfactant, a fixative, and an ethoxylated alkyl phenol or an ethoxylated alkyl alcohol; quality control in hematology
03/29/2007US20070072286 Label-free detection of biomolecules
03/29/2007US20070072282 Bovine adeno-associated viral (baav) vector and uses thereof
03/29/2007US20070072270 PS4 variant with a proline substitution, derivable from a parent polypeptide, having non-maltogenic exoamylase activity; higher thermostability compared to the parent polypeptide
03/29/2007US20070072257 Multiwell plate assembly for use in high throughput assays
03/29/2007US20070072252 Method for the in vitro titration of an ncta application thereof in a method for the evaluation and/or monitoring of a biological product production method
03/29/2007US20070072251 In vivo imaging using peptide derivatives
03/29/2007US20070072250 Method and system for analysis of cancer biomarkers using proteome image mining
03/29/2007US20070072249 Human cytokine and alpha-helix-containing polypeptides
03/29/2007US20070072248 Constitutively activated human G protein coupled receptors
03/29/2007US20070072247 Methods and reagents for the analysis and purification of polysaccharides
03/29/2007US20070072246 Cell-based assays for determining drug action
03/29/2007US20070072245 Method and means for the determination of defined states or modifications in the mucus of the uterus or in the epithelium of other organs
03/29/2007US20070072244 Use of the endo-180 gene and polypeptide for diagnosis and treatment
03/29/2007US20070072243 Multiplex screening for lysosomal sotrage disorders (lsds)
03/29/2007US20070072242 Immunoassay method and kit to leucomalachite green and malachite green
03/29/2007US20070072241 Diagnostic methods for age related macular degeneration
03/29/2007US20070072240 Method for producing an in vitro expression library
03/29/2007US20070072239 Pharmaceutical compositions and methods of using secreted frizzled related protein
03/29/2007US20070072238 Wnt-frizzled chimera
03/29/2007US20070072237 Method of assessing rheumatoid arthritis by measuring rheumatoid factor and interleukin-6
03/29/2007US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors
03/29/2007US20070072235 Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
03/29/2007US20070072234 Protein capable of binding plasticizer
03/29/2007US20070072233 Methods and systems for facilitating the diagnosis and treatment of schizophrenia
03/29/2007US20070072228 ERCC2 polymorphisms
03/29/2007US20070072227 Indicators can be used as an acute predictive marker for monitoring and screening for Notch-related toxicity due to gamma-secretase inhibition in both animal models and humans; used to identify preferred doses of test compounds and thereby prevent medical complications in clinical trials
03/29/2007US20070072224 Diagnosis and treatment of tumor-suppressor associated disorders
03/29/2007US20070072221 Methods to screen peptide display libraries using minicell display
03/29/2007US20070072218 A polynucleotide encoding a polypeptide having the amino acid sequence of SEQ ID NO:1, sequence operably linked to a heterologous promoter selected from hsp68, SV40, CMV, GAL4UAS, HSV and beta -actin; anticarcinogenic agents
03/29/2007US20070072217 XAF genes and polypeptides: methods and reagents for modulating apoptosis